Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

ConclusionsIn a limited population of AF patients with preserved LV function and PET CFC indicating occult CAD, treatment with 1C AADs appears not to increase mortality. A larger study would be required to confidently assess safety of these drugs in this context.This article is protected by copyright. All rights reserved.

Source: Journal of Cardiovascular Electrophysiology - January 7, 2020 Category: Cardiology Authors: Peter G. Pantlin, Robert M. Bober, Michael L. Bernard, Sammy Khatib, Glenn M. Polin, Paul A. Rogers, Daniel P. Morin Tags: ORIGINAL ARTICLE Source Type: research